Department of Urology, Northwestern University Medical School, Chicago, IL 60611, USA.
J Sex Med. 2011 Jan;8(1):78-89. doi: 10.1111/j.1743-6109.2010.02001.x. Epub 2010 Aug 30.
Erectile dysfunction (ED) is a serious medical condition that affects 16-82% of prostate cancer patients treated by radical prostatectomy and current treatments are ineffective in 50-60% of prostatectomy patients. The reduced efficacy of treatments makes novel therapeutic approaches to treat ED essential. The secreted protein Sonic hedgehog (SHH) is a critical regulator of penile smooth muscle and apoptosis that is decreased in cavernous nerve (CN) injury and diabetic ED models. Past studies using Affi-Gel beads have shown SHH protein to be effective in suppressing apoptosis caused by CN injury.
We hypothesize that SHH protein delivered via novel peptide amphiphile (PA) nanofibers will be effective in suppressing CN injury-induced apoptosis.
Adult Sprague Dawley rats (n=50) were used to optimize PA injection in vivo. PA with SHH protein (n=16) or bovine serum albumin (BSA) (control, n=14) was injected into adult rats that underwent bilateral CN cut. Rats were sacrificed at 2, 4, and 7 days. Alexa Fluor-labeled SHH protein was used to determine the target of SHH signaling (n=3).
Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) and semiquantitative immunohistochemical analysis for SHH protein and cluster differentiation protein three (CD3) were performed.
SHH-PA caused a 25% and 16% reduction in apoptosis at 4 and 7 days after CN injury and a 9.3% and 19% increase in SHH protein at 4 and 7 days after CN injury. CD3 protein was not observed in SHH-PA-treated penis. In vitro, 73% of SHH protein diffused from PA within 6 days. Labeled SHH was observed in smooth muscle.
PA technology is effective in delivering SHH protein to the penis and SHH is effective in suppressing CN injury-induced apoptosis. These results suggest substantial translational potential of this methodology and show that only a short duration of SHH treatment is required to impact the apoptotic index.
勃起功能障碍(ED)是一种严重的医学病症,影响接受根治性前列腺切除术的前列腺癌患者的 16-82%,而当前的治疗方法在 50-60%的前列腺切除术患者中无效。治疗效果的降低使得寻求治疗 ED 的新的治疗方法成为必要。分泌蛋白 Sonic hedgehog(SHH)是阴茎平滑肌和细胞凋亡的关键调节因子,在海绵体神经(CN)损伤和糖尿病 ED 模型中减少。过去使用 Affi-Gel 珠的研究表明,SHH 蛋白可有效抑制 CN 损伤引起的细胞凋亡。
我们假设通过新型肽两亲物(PA)纳米纤维递送 SHH 蛋白将有效抑制 CN 损伤诱导的细胞凋亡。
使用成年 Sprague Dawley 大鼠(n=50)优化体内 PA 注射。将含有 SHH 蛋白的 PA(n=16)或牛血清白蛋白(BSA)(对照,n=14)注射到接受双侧 CN 切割的成年大鼠中。大鼠在 2、4 和 7 天时被处死。使用 Alexa Fluor 标记的 SHH 蛋白来确定 SHH 信号的靶标(n=3)。
末端脱氧核苷酸转移酶 dUTP 缺口末端标记(TUNEL)和 SHH 蛋白和簇分化蛋白 3(CD3)的半定量免疫组织化学分析。
CN 损伤后 4 天和 7 天,SHH-PA 分别使细胞凋亡减少 25%和 16%,CN 损伤后 4 天和 7 天,SHH 蛋白增加 9.3%和 19%。在 SHH-PA 处理的阴茎中未观察到 CD3 蛋白。体外,PA 内 73%的 SHH 蛋白在 6 天内扩散。标记的 SHH 被观察到在平滑肌中。
PA 技术可有效将 SHH 蛋白递送到阴茎中,SHH 可有效抑制 CN 损伤诱导的细胞凋亡。这些结果表明该方法具有很大的转化潜力,并表明仅需短时间的 SHH 治疗即可影响细胞凋亡指数。